Kuehn Law is investigating whether certain officers and directors of Picard Medical, Inc. breached their fiduciary duties to shareholders. The investigation follows a federal securities lawsuit alleging that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, that insiders or affiliates used offshore or nominee accounts to facilitate coordinated dumping of shares during a price inflation campaign, and that Picard’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price. Shareholders who currently own PMI and purchased prior to September 2, 2025 are encouraged to contact the law firm.
Picard Medical, Inc.Investigation for breach of fiduciary duties and alleged fraudulent stock promotion scheme.